| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Incontinence, Stress | 16 | 2019 | 196 | 4.050 |
Why?
|
| Sex Reassignment Surgery | 6 | 2022 | 41 | 3.560 |
Why?
|
| Suburethral Slings | 9 | 2016 | 75 | 2.190 |
Why?
|
| Urologic Surgical Procedures | 10 | 2021 | 147 | 1.760 |
Why?
|
| Transsexualism | 3 | 2021 | 34 | 1.440 |
Why?
|
| Urethra | 6 | 2020 | 115 | 1.320 |
Why?
|
| Urinary Bladder | 5 | 2022 | 246 | 1.300 |
Why?
|
| Urodynamics | 8 | 2016 | 122 | 1.290 |
Why?
|
| Pelvic Floor Disorders | 7 | 2021 | 55 | 1.280 |
Why?
|
| Penile Prosthesis | 2 | 2019 | 24 | 1.250 |
Why?
|
| Surgical Flaps | 5 | 2022 | 249 | 1.220 |
Why?
|
| Vagina | 4 | 2022 | 173 | 1.070 |
Why?
|
| Robotic Surgical Procedures | 2 | 2022 | 306 | 1.030 |
Why?
|
| Urology | 3 | 2022 | 117 | 0.930 |
Why?
|
| Urination | 3 | 2016 | 37 | 0.860 |
Why?
|
| Urinary Bladder, Neurogenic | 2 | 2016 | 25 | 0.840 |
Why?
|
| Prostheses and Implants | 6 | 2019 | 124 | 0.790 |
Why?
|
| Sexual Health | 1 | 2022 | 17 | 0.780 |
Why?
|
| Surgical Mesh | 3 | 2019 | 123 | 0.770 |
Why?
|
| Penis | 3 | 2019 | 60 | 0.770 |
Why?
|
| Prosthesis Implantation | 4 | 2012 | 126 | 0.660 |
Why?
|
| Catastrophization | 1 | 2019 | 7 | 0.660 |
Why?
|
| Penile Implantation | 1 | 2019 | 14 | 0.650 |
Why?
|
| Urological Agents | 1 | 2018 | 5 | 0.650 |
Why?
|
| Neuromuscular Agents | 2 | 2010 | 26 | 0.640 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2010 | 50 | 0.620 |
Why?
|
| Pelvic Floor | 7 | 2022 | 85 | 0.620 |
Why?
|
| Biocompatible Materials | 1 | 2018 | 198 | 0.570 |
Why?
|
| Female | 41 | 2022 | 46200 | 0.570 |
Why?
|
| Humans | 61 | 2022 | 89349 | 0.540 |
Why?
|
| Urinary Incontinence | 5 | 2018 | 213 | 0.500 |
Why?
|
| Patient Satisfaction | 6 | 2019 | 461 | 0.480 |
Why?
|
| Surgeons | 4 | 2021 | 248 | 0.460 |
Why?
|
| Postoperative Complications | 11 | 2022 | 2284 | 0.450 |
Why?
|
| Urination Disorders | 2 | 2005 | 50 | 0.430 |
Why?
|
| Laparoscopy | 1 | 2020 | 773 | 0.420 |
Why?
|
| Prostatectomy | 5 | 2008 | 477 | 0.410 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 253 | 0.400 |
Why?
|
| Prospective Studies | 11 | 2016 | 4289 | 0.370 |
Why?
|
| Fluoroscopy | 2 | 2021 | 123 | 0.360 |
Why?
|
| Radiology | 3 | 2021 | 201 | 0.360 |
Why?
|
| Terminology as Topic | 4 | 2012 | 221 | 0.350 |
Why?
|
| Sex Reassignment Procedures | 2 | 2021 | 4 | 0.340 |
Why?
|
| Quality of Life | 6 | 2018 | 1668 | 0.340 |
Why?
|
| Surveys and Questionnaires | 7 | 2016 | 2623 | 0.330 |
Why?
|
| Middle Aged | 24 | 2021 | 25974 | 0.330 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2010 | 90 | 0.320 |
Why?
|
| Follow-Up Studies | 10 | 2014 | 3666 | 0.300 |
Why?
|
| Adult | 19 | 2022 | 26607 | 0.300 |
Why?
|
| Societies, Medical | 2 | 2022 | 575 | 0.300 |
Why?
|
| Male | 24 | 2022 | 42410 | 0.300 |
Why?
|
| Defecography | 3 | 2021 | 3 | 0.290 |
Why?
|
| Defecation | 3 | 2021 | 23 | 0.290 |
Why?
|
| Catheterization | 1 | 2008 | 237 | 0.280 |
Why?
|
| Pelvic Organ Prolapse | 2 | 2022 | 154 | 0.270 |
Why?
|
| Diagnostic Techniques, Urological | 2 | 2014 | 14 | 0.270 |
Why?
|
| Lumbosacral Plexus | 1 | 2005 | 9 | 0.250 |
Why?
|
| Time Factors | 8 | 2021 | 5337 | 0.250 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2005 | 21 | 0.250 |
Why?
|
| Electric Stimulation Therapy | 1 | 2005 | 46 | 0.240 |
Why?
|
| Kidney Transplantation | 2 | 2016 | 850 | 0.240 |
Why?
|
| Cough | 1 | 2004 | 55 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2021 | 3448 | 0.240 |
Why?
|
| Retrospective Studies | 4 | 2022 | 9057 | 0.230 |
Why?
|
| Consensus | 6 | 2021 | 356 | 0.230 |
Why?
|
| Feasibility Studies | 3 | 2020 | 780 | 0.230 |
Why?
|
| Treatment Outcome | 10 | 2021 | 8241 | 0.220 |
Why?
|
| Aged | 16 | 2021 | 19165 | 0.220 |
Why?
|
| Perineum | 1 | 2022 | 36 | 0.210 |
Why?
|
| Health Services for Transgender Persons | 1 | 2021 | 2 | 0.200 |
Why?
|
| Colorectal Surgery | 1 | 2021 | 22 | 0.190 |
Why?
|
| Societies, Scientific | 1 | 2021 | 43 | 0.190 |
Why?
|
| Urogenital Surgical Procedures | 2 | 2011 | 10 | 0.190 |
Why?
|
| Transplants | 2 | 2011 | 41 | 0.180 |
Why?
|
| Clitoris | 1 | 2020 | 4 | 0.180 |
Why?
|
| Disorders of Sex Development | 1 | 2020 | 18 | 0.180 |
Why?
|
| Peritoneum | 1 | 2020 | 57 | 0.170 |
Why?
|
| Injections | 2 | 2018 | 116 | 0.170 |
Why?
|
| Penile Erection | 1 | 2019 | 22 | 0.170 |
Why?
|
| Transgender Persons | 1 | 2021 | 107 | 0.170 |
Why?
|
| Operative Time | 1 | 2020 | 143 | 0.170 |
Why?
|
| Blood Loss, Surgical | 1 | 2020 | 115 | 0.170 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 217 | 0.160 |
Why?
|
| Coitus | 1 | 2018 | 20 | 0.160 |
Why?
|
| Free Tissue Flaps | 1 | 2019 | 49 | 0.160 |
Why?
|
| Aged, 80 and over | 8 | 2015 | 6811 | 0.150 |
Why?
|
| Models, Educational | 1 | 2017 | 49 | 0.150 |
Why?
|
| Urinary Reservoirs, Continent | 2 | 2009 | 14 | 0.140 |
Why?
|
| Hydrodynamics | 1 | 2016 | 19 | 0.140 |
Why?
|
| Contraindications, Procedure | 1 | 2016 | 7 | 0.140 |
Why?
|
| Length of Stay | 1 | 2020 | 736 | 0.130 |
Why?
|
| Recurrence | 2 | 2010 | 1144 | 0.130 |
Why?
|
| Pain | 1 | 2019 | 400 | 0.130 |
Why?
|
| Delivery, Obstetric | 1 | 2016 | 118 | 0.130 |
Why?
|
| Obesity | 1 | 2022 | 971 | 0.130 |
Why?
|
| Equipment Design | 2 | 2014 | 417 | 0.130 |
Why?
|
| Monitoring, Ambulatory | 1 | 2015 | 32 | 0.130 |
Why?
|
| Simulation Training | 1 | 2017 | 97 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 312 | 0.130 |
Why?
|
| Body Weight | 1 | 2016 | 452 | 0.130 |
Why?
|
| Erectile Dysfunction | 3 | 2006 | 75 | 0.120 |
Why?
|
| Young Adult | 3 | 2020 | 6312 | 0.120 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2015 | 67 | 0.120 |
Why?
|
| Urinary Retention | 1 | 2014 | 42 | 0.120 |
Why?
|
| Tissue Engineering | 1 | 2016 | 185 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 191 | 0.120 |
Why?
|
| Education, Medical | 1 | 2017 | 243 | 0.110 |
Why?
|
| Colon | 3 | 2021 | 510 | 0.110 |
Why?
|
| Pregnancy | 2 | 2022 | 3018 | 0.110 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 345 | 0.110 |
Why?
|
| Prostatic Neoplasms | 4 | 2006 | 1769 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2016 | 1097 | 0.100 |
Why?
|
| Urologic Surgical Procedures, Male | 2 | 2009 | 14 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2012 | 123 | 0.100 |
Why?
|
| United States | 5 | 2021 | 6987 | 0.100 |
Why?
|
| Anatomic Landmarks | 2 | 2021 | 30 | 0.100 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2007 | 171 | 0.100 |
Why?
|
| Colostomy | 1 | 2011 | 13 | 0.100 |
Why?
|
| Multiple Trauma | 1 | 2011 | 34 | 0.100 |
Why?
|
| Urinary Diversion | 2 | 2004 | 42 | 0.090 |
Why?
|
| Abdominal Injuries | 1 | 2011 | 46 | 0.090 |
Why?
|
| Pelvic Bones | 1 | 2011 | 43 | 0.090 |
Why?
|
| Anal Canal | 1 | 2011 | 88 | 0.090 |
Why?
|
| Injections, Intramuscular | 1 | 2010 | 64 | 0.090 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2012 | 148 | 0.090 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2011 | 113 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2011 | 128 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2007 | 401 | 0.080 |
Why?
|
| Prosthesis Design | 2 | 2007 | 298 | 0.080 |
Why?
|
| Pelvis | 2 | 2006 | 96 | 0.080 |
Why?
|
| Preoperative Care | 3 | 2008 | 396 | 0.080 |
Why?
|
| Urinary Catheterization | 1 | 2008 | 36 | 0.080 |
Why?
|
| Valsalva Maneuver | 1 | 2008 | 6 | 0.080 |
Why?
|
| Surgical Instruments | 1 | 2008 | 57 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2017 | 1045 | 0.080 |
Why?
|
| Pressure | 2 | 2008 | 165 | 0.080 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2006 | 72 | 0.070 |
Why?
|
| Interleukin-2 | 2 | 1997 | 251 | 0.070 |
Why?
|
| Prevalence | 2 | 2022 | 1243 | 0.070 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 94 | 0.070 |
Why?
|
| Contrast Media | 2 | 2021 | 1091 | 0.070 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2006 | 69 | 0.060 |
Why?
|
| Apomorphine | 1 | 2005 | 10 | 0.060 |
Why?
|
| Dopamine Agonists | 1 | 2005 | 27 | 0.060 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2005 | 20 | 0.060 |
Why?
|
| Skin, Artificial | 1 | 2004 | 8 | 0.060 |
Why?
|
| Urinary Bladder Diseases | 1 | 2004 | 41 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1840 | 0.060 |
Why?
|
| Abdomen | 1 | 2004 | 122 | 0.060 |
Why?
|
| Electrodes, Implanted | 1 | 2005 | 177 | 0.060 |
Why?
|
| Alprostadil | 1 | 2003 | 25 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2006 | 548 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 2 | 1997 | 437 | 0.050 |
Why?
|
| Gender Dysphoria | 1 | 2021 | 9 | 0.050 |
Why?
|
| Gender Identity | 1 | 2021 | 53 | 0.050 |
Why?
|
| Kidney Neoplasms | 2 | 1997 | 638 | 0.050 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2021 | 58 | 0.050 |
Why?
|
| Interdisciplinary Communication | 1 | 2021 | 131 | 0.050 |
Why?
|
| Patient Positioning | 1 | 2021 | 65 | 0.040 |
Why?
|
| Rectum | 1 | 2021 | 148 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2009 | 2661 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2022 | 341 | 0.040 |
Why?
|
| Radiography | 1 | 2000 | 809 | 0.040 |
Why?
|
| Prostate-Specific Antigen | 1 | 2000 | 360 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2021 | 360 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2000 | 712 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 2758 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 742 | 0.040 |
Why?
|
| Adolescent | 1 | 2010 | 9263 | 0.040 |
Why?
|
| Incidence | 1 | 2022 | 1595 | 0.040 |
Why?
|
| Aging | 1 | 2022 | 718 | 0.040 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1997 | 103 | 0.030 |
Why?
|
| Self Report | 1 | 2017 | 297 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2018 | 311 | 0.030 |
Why?
|
| Catheters | 1 | 2015 | 76 | 0.030 |
Why?
|
| Prazosin | 1 | 1995 | 10 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1995 | 31 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2006 | 1723 | 0.030 |
Why?
|
| Prostatic Hyperplasia | 1 | 1995 | 91 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1877 | 0.030 |
Why?
|
| Cystectomy | 2 | 2009 | 110 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 645 | 0.030 |
Why?
|
| Colon, Sigmoid | 1 | 2009 | 6 | 0.020 |
Why?
|
| Cecum | 1 | 2009 | 69 | 0.020 |
Why?
|
| Wound Healing | 1 | 2011 | 359 | 0.020 |
Why?
|
| Ileum | 1 | 2009 | 160 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5498 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 590 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 306 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2008 | 302 | 0.020 |
Why?
|
| Injections, Subcutaneous | 2 | 1997 | 125 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 683 | 0.020 |
Why?
|
| Subtraction Technique | 1 | 2006 | 132 | 0.020 |
Why?
|
| Hydrostatic Pressure | 1 | 2004 | 4 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2005 | 110 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2006 | 502 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2004 | 287 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2003 | 38 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2005 | 231 | 0.010 |
Why?
|
| Testosterone | 1 | 2005 | 276 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 200 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 1242 | 0.010 |
Why?
|
| Reoperation | 1 | 2004 | 599 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 2018 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2005 | 1719 | 0.010 |
Why?
|
| Prognosis | 1 | 2006 | 3783 | 0.010 |
Why?
|
| Contraindications | 1 | 1996 | 70 | 0.010 |
Why?
|
| Vinblastine | 1 | 1996 | 108 | 0.010 |
Why?
|
| Methotrexate | 1 | 1996 | 250 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 2015 | 0.010 |
Why?
|
| Doxorubicin | 1 | 1996 | 301 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1996 | 487 | 0.010 |
Why?
|
| Remission Induction | 1 | 1997 | 740 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1995 | 155 | 0.010 |
Why?
|
| Cisplatin | 1 | 1996 | 618 | 0.010 |
Why?
|
| Sex Factors | 1 | 1996 | 1066 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 1719 | 0.010 |
Why?
|
| Survival Rate | 1 | 1997 | 1901 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1996 | 2566 | 0.000 |
Why?
|